Company / Current Liabilities
TENAX THERAPEUTICS, INC. Current Liabilities History
FY2012-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$7.2M
FY2025
5-year range
$2.6M / $7.2M
FY2021-FY2025
Trend
+52.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities has fluctuated over the past 7 years, ranging from $2M in FY2013 to $7M in FY2025.
Based on SEC 10-K filings.
$7M in FY2025 with a 10-year CAGR of +10.8%.
Increased from $6M to $7M over the past 9 years.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +10.8%
Key checks
Key Insights
- In FY2025, current liabilities increased 52.5% year-over-year.
- Lowest current liabilities in the period was in FY2013.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.2M | +52.5% |
| FY2024 | $4.7M | -24.3% |
| FY2016 | $6.2M | +141.1% |
| FY2015 | $2.6M | +0.0% |
| FY2014 | $2.6M | +34.6% |
| FY2013 | $1.9M | -38.9% |
| FY2012 | $3.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026